Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 59 | Issue 3s | 2025 | pp. s969–s977Open access
Exploring the Nephroprotective Efficacy of Leucaena leucocephala Seeds in Mitigating Cisplatin-Induced Renal Damage
- 1*,
- 1*,
- 1*,
- 1*,
- 1*,
- 1*
- 1 Department of Pharmacology, Karnataka College of Pharmacy, Bangalore, Karnataka, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Umar Farooq Mir
Department of Pharmacology, Karnataka College of Pharmacy, Bangalore, Karnataka, INDIA.
Email: deepakjha736@gmail.com
Copyright: © 2025 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2025
- Received:
- May 5, 2024
- Accepted:
- Feb 11, 2025
- DOI:
- 10.5530/ijper.20251234
How to cite
Mir, U. F., Jha, D. K., Chatterjee, S., Nagaraj, H., Fathima, M., & Sah, S. K. (2025). Exploring the Nephroprotective Efficacy of Leucaena leucocephala Seeds in Mitigating Cisplatin-Induced Renal Damage. Indian Journal of Pharmaceutical Education and Research, 59(3s), s969–s977. https://doi.org/10.5530/ijper.20251234
Abstract
Objectives:
The study aimed to evaluate the nephroprotective effects of the methanolic extract of Leucaena leucocephala seeds against Cisplatin-Induced Nephrotoxicity (CIN) in rats through biochemical, antioxidant and histopathological assessments.
Materials and Methods:
2 experimental models were employed, using 30 Wistar rats in each model, divided into 5 groups of 6 animals each. In Model 1, the normal control group received normal saline (10 mL/kg, p.o.), the disease control group received cisplatin (2 mg/kg, i.p.) on alternate days, the standard group was treated with Vitamin E (250 mg/kg, p.o.) and the test groups were administered Leucaena leucocephala methanolic extract at doses of 250 mg/kg and 500 mg/kg. Model 2 followed the same group allocation, but the disease control group received a single dose of cisplatin (8 mg/ kg, i.p.).
Results:
In both models, cisplatin administration caused significant nephrotoxicity, characterized by elevated serum creatinine, urea, uric acid, Blood Urea Nitrogen (BUN) and electrolyte levels (Na⁺, K⁺, Cl- and Ca⁺⁺). Additionally, it reduced antioxidant enzyme levels (SOD, CAT and GSH) and increased pro-inflammatory cytokines such as TNF-α. Histopathological analysis revealed marked structural damage, including tubular dilation, glomerular inflammation and disrupted renal architecture. Treatment with the methanolic extract of Leucaena leucocephala showed dose-dependent nephroprotective effects. Both doses (250 mg/kg and 500 mg/ kg) significantly reduced renal function markers, improved antioxidant enzyme levels and decreased pro-inflammatory cytokines. Histological improvements were evident, with reduced inflammation, tubular dilation and preservation of glomerular and tubular structures, especially at the higher dose of 500 mg/kg.
Conclusion:
These findings suggest that the methanolic extract of Leucaena leucocephala effectively mitigates cisplatin-induced nephrotoxicity by normalizing biochemical markers, enhancing antioxidant defense and protecting renal histology. The study highlights its potential as a natural therapeutic agent for managing cisplatin-induced renal damage.
Keywords
Subject
Article metadata
| Title | Exploring the Nephroprotective Efficacy of Leucaena leucocephala Seeds in Mitigating Cisplatin-Induced Renal Damage |
|---|---|
| Authors | Umar Farooq Mir; Deepak Kumar Jha; Sandipan Chatterjee; Harshitha Nagaraj; Mehdi Fathima; Saroj Kumar Sah |
| Affiliations | Department of Pharmacology, Karnataka College of Pharmacy, Bangalore, Karnataka, INDIA. |
| Corresponding author | deepakjha736@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 59, Issue 3s (2025) |
Also in this issue
- Mesoporous Silica Nanoparticles: A Promising Portal for Diagnosis and Treatment for Chronic Diseasespp. s776–s787
- Nanostructured Lipid Carrier to Improve Oral Bioavailabilitypp. s788–s801
- A Review on Preparation Methods of Drug Loading Solid Lipid Nanoparticles with the Application in various Cancer Treatmentpp. s802–s813
- A Comprehensive Review on Management of Insulin Resistance Disorder by Innovative Technologies and Advancement of Precision Medicinal Therapiespp. s814–s824
- Formulation and Evaluation of Orally Disintegrating Tablet Containing Aripiprazole in the Context of Quality by Design Approachpp. s825–s836